logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure GPS-17. Last year prevalence of amphetamines, ecstasy and cocaine among young adults (15 to 34 years)


Sample sizes (n) refer to the number of respondents for 15- to 34-year-old group. For number of respondents for the whole surveys, see Epidemiological Tables on Population Surveys in the 2007 statistical bulletin.

Data are from the most recent national surveys available in each country (see Epidemiological Tables on Population Surveys, EMCDDA statistical bulletin).

For young adults, the EMCDDA standard age range is 15 to 34 years (Denmark and UK from 16, Estonia, Hungary and Germany from 18 years). Variations in age ranges may slightly influence some national differences. In some countries the figures were recalculated at national level, to adapt as far as possible to standard EMCDDA age groups.

Bulgaria: 2005; n=433

Czech Republic: 2004;n=1414

Denmark: 2005; n=3583

Germany: 2003; n=3775

Estonia: 2003; n=646

Ireland: 2002/03; n=

Greece: 2004; n=2620

Spain: 2005/06; n=14699

France: 2005; n=10855

Italy: 2005; n=16552

Cyprus: 2006; n=1753

Latvia: 2003; n=4534 15-64 y.

Lithuania: 2004; n=1814

Hungary: 2003; n=2319

Netherlands: 2005; n=

Austria: 2004; n=1754

Poland: 2002; n=3148 16+ y.

Portugal: 2001; n=5472

Slovakia: 2004; n=578

Finland: 2004; n=1031

UK (E&W): 2005/06; n=12329

Norway: 2004; n=1238



Figure GPS-23 part (i)

See also Tables GPS-11 and GPS-18

See also 'General notes for interpreting data' on the Explanatory notes and help page.


Reitox national reports 2006, taken from surveys, reports or scientific articles.

Page last updated: Wednesday, 14 November 2007